1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow T-Cell Lymphocytic Leukemia: new trials by email Literature Review of T-Cell Lymphocytic Leukemia trials Research Report on T-Cell Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients TBICy, BuCy - T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | Phase 3 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 430 | 2024-12-01 | 2024-11-05 |
| Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies Fludarabine + Cyclophosphamide + CAR7-T Cells - T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia | Phase 1 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 24 | 2021-04-15 | 2022-03-16 |
Leukemia, T-Cell (2) · Leukemia, Prolymphocytic, T-Cell (1) · Lymphoma, T-Cell (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Leukemia, Prolymphocytic (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Cyclophosphamide (1) · fludarabine (1)
The First Affiliated Hospital of Soochow University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (2)
Heng Mei (1)